BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TRAVERE THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · Registration - Amendment

TRAVERE THERAPEUTICS

via TRAVERE THERAPEUTICS

4th Quarter (Oct 1 - Dec 31) · 2022Posted Jan 30, 2023Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: TRAVERE THERAPEUTICS
Description: Biopharmaceuticals
Location: California · United States of America

Registrant

Firm: TRAVERE THERAPEUTICS
Description: Pharmaceuticals
Location: San Diego, California, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to rare disease research, detection, diagnosis, treatment, care, and reimbursement.
LobbyistsCHRISTOPHER PORTER · ROSE GALLAGHER

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.